Drug Target Identification in Tissues by Thermal Proteome Profiling

Area of Science:

• Biochemistry
• Pharmacology
• Proteomics

Background:

• Drug target deconvolution is crucial for accelerating drug discovery and predicting adverse reactions.
• Mass spectrometry-based methods exist, but often require compound modification.
• Thermal proteome profiling (TPP) is a unique method that identifies intracellular drug targets in living cells without requiring compound modification.

Purpose of the Study:

• To highlight the advantages and applications of Thermal Proteome Profiling (TPP) in drug discovery.
• To discuss recent advancements in TPP for studying protein-drug interactions and biological phenomena.
• To emphasize the potential of TPP in understanding disease mechanisms and designing improved therapeutics.

Main Methods:

• Thermal Proteome Profiling (TPP) measures changes in protein thermal stability upon drug interaction.
• TPP analyzes protein lysates using mass spectrometry to quantify proteome-wide stability shifts.
• The method is applied in living cells, obviating the need for compound modification.

Main Results:

• TPP successfully identifies direct drug targets and off-targets by detecting changes in protein melting profiles.
• Recent TPP developments enable its application in complex biological systems, including tissues.
• The approach facilitates holistic studies of drug treatment and disease mechanisms.

Conclusions:

• TPP is a powerful, versatile technique for drug target deconvolution in various biological contexts.
• Advancements in TPP offer new avenues for understanding fundamental biology and developing novel therapeutics.
• TPP contributes to the design of safer and more effective drugs by identifying both intended and unintended molecular interactions.